Top Markets
#1 Cortex Cortex +173.72%
#2 Helium Helium +60.27%
#3 GEKKO GEKKO +50.71%
#4 Pons Pons +20.78%
#5 ADO Protocol ADO Protocol +17.96%
#6 o1.exchange o1.exchange +13.64%
#7 Collect on Fanable Collect on Fanable +12.30%
#8 Status Status +11.10%
#9 龙虾 (Lobster) 龙虾 (Lobster) +10.81%
#10 Siren Siren +10.57%
Coin of the day
Cortex Cortex
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Kedudukan dalam Saham #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Harga Saham
$0.2219522
Disegerakkan terakhir: 2025-09-11
Modal Pasaran
$1.10B
Perubahan (1 hari)
0.04%
Perubahan (1 tahun)
0.17%
Negara
CN
Perdagangan Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Kategori

Financial Services
Bilangan saham terbitan bagi Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Bilangan saham terbitan setakat September 2024: 4.94B
Menurut laporan kewangan terkini dan harga saham Hubei Biocause Pharmaceutical Co., Ltd., bilangan saham terbitan semasa ialah 4.94B. Pada akhir December 2022, syarikat mempunyai 4.94B saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Hubei Biocause Pharmaceutical Co., Ltd. (000627) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 4.94B -1.45%
2023 5.01B 1.48%
2022 4.94B 0.00%
2021 4.94B 0.00%
2020 4.94B 0.15%
2019 4.93B 0.41%
2018 4.91B 11.14%
2017 4.42B 9.35%
2016 4.04B 194.28%
2015 1.37B -1.67%
2014 1.40B 3.73%
2013 1.35B 2.51%
2012 1.31B -3.09%
2011 1.36B 0.53%
2010 1.35B -0.73%
2009 1.36B 8.23%
2008 1.26B 13.94%
2007 1.10B 0.57%
2006 1.10B 86.84%
2005 586.33M -47.49%
2004 1.12B 0.00%
2003 1.12B 0.00%
2002 1.12B 90.44%
2001 586.33M 0.00%
2000 586.33M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
China Life Insurance Company Limited China Life Insurance Company Limited
China Life Insurance Company Limited
601628.SS
 28.27B 472.09%
CN
AIA Group Limited AIA Group Limited
AIA Group Limited
1299.HK
 10.42B 110.92%
HK
Manulife Financial Corporation Manulife Financial Corporation
Manulife Financial Corporation
MFC.TO
 - -
CA
Fubon Financial Holding Co., Ltd. Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd.
2881.TW
 - -
TW
MetLife, Inc. MetLife, Inc.
MetLife, Inc.
MET.US
 - -
US